Previously we have shown that an elevated baseline neutrophil-to-lymphocyte ratio (NLR) was associated with a high risk of recurrence in patients with differentiated thyroid cancer. The clinical significance of the longitudinal changes in NLR following treatment remained unestablished. | An increased neutrophil-to-lymphocyte ratio predicts incomplete response to therapy in differentiated thyroid cancer